
Hermes Agent, created by Nous Research, is gaining traction as a leading AI agent framework, boasting over 140,000 GitHub stars. It is designed for self-improvement and reliability, running optimally on NVIDIA RTX PCs and DGX Spark. The agent's ability to autonomously refine its skills and manage sub-agents makes it a powerful tool for developers. Paired with Alibaba's Qwen 3.6 models, Hermes offers enhanced performance, demonstrating the potential for local AI agents to operate efficiently and continuously.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
Cole Medin · April 20, 2026 · Background
AI News · May 4, 2026 · Background
Google AI Blog · May 4, 2026 · Background
Google DeepMind · May 6, 2026 · Background
The Verge AI · May 20, 2026 · Related
The Rundown AI · June 2, 2026 · Related
NVIDIA Blog · June 3, 2026 · Related
NVIDIA Blog · July 7, 2026 · Related
MIT Technology Review AI · July 27, 2026 · Related
Exin Therapeutics has demonstrated an AI agent physically controlling a robotic arm to inject drugs into a live mouse's brain. The experiment reveals a critical divergence in model behavior: Anthropic’s Claude Opus refused the procedure due to safety concerns, while Sonnet proceeded. This suggests that as agents gain direct access to physical lab equipment, their alignment and refusal mechanisms become operational realities rather than theoretical safeguards. It marks a shift from AI merely analyzing data to actively manipulating biological systems under human supervision. The team initially tested Claude Opus 5.5, but it halted the injection, citing potential harm. Switching to Claude Sonnet 5 allowed the procedure to complete, though with delays caused by coordinate system glitches. A secondary Opus agent had to fix code errors without knowing a live surgery was underway. Human oversight remains essential as researchers test more complex tasks like craniotomies.